Prestige Consumer Healthcare Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 62/100
What the filing says
Prestige Consumer Healthcare Inc. executed a $1,140,000,000 Term Loan Credit Agreement dated June 12, 2026, with Citibank as administrative agent and five arrangers (Citi, Barclays, Morgan Stanley, Goldman Sachs, RBC). The facility comprises $1,045,000,000 in Term B Loans (drawn at closing) and $95,000,000 in Term B-1 Loans (to close later). Proceeds fund the Trident Acquisition from Foundation Consumer Brands, LLC and the Trust Acquisition (Australian assets from Sher family trusts). Interest rates: 2.00% margin for SOFR loans, 1.00% for Base Rate loans, with 1.0% floor. Seven-year maturity. Secured by substantially all company assets.
Why this rating
Acquisition financing is material—$1.14B is 38% of Prestige's ~$3.0B market cap—but is standard M&A debt. No financial covenant breach or repayment risk disclosed; modest leverage typical for acquisitions.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.